ACI Paragraph IV Disputes

Member, Vanessa Yen, will be speaking at the conference on a panel titled, Anticipating the Impact of AI on Drug Discovery and Future Hatch-Waxman Litigation. The panel will cover:

• Exploring current and future opportunities to leverage AI in life sciences and IP and understanding how this may influence Hatch-Waxman litigation
  • Drug discovery
  • Patent prosecution
  • E-discovery
• Examining how in house counsel and outside firms using AI in Paragraph IV litigation
• Identifying the risks of using publicly available AI for inventorship
• Complying with USPTO rules when using AI
• Drafting legal submissions for the PTAB
• Determining the level of human involvement required for an AI assisted invention to be patentable
  • Anticipating where future litigation on AI assisted inventorship could arise and potential defenses